Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. is a registered legal entity registered in China, and its current status with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is active. Its registered address on file is Harbin, China. 2 shareholders are on record for Harbin Pharmaceutical Group Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last updated on 29 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of Harbin Pharmaceutical Group Co., Ltd.
Two shareholders are currently on record for Harbin Pharmaceutical Group Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 81% — a majority holding — followed by DFA Emerging Markets Small Cap Series at 19%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data-provider feed — rows as supplied to Zavia for SAMR — public search via GSXT (National Enterprise Credit Information Publicity System), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 81% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| DFA Emerging Markets Small Cap Series | 19% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) |
Officers
5
Directors and officers of Harbin Pharmaceutical Group Co., Ltd.
The Vp, Secretary & Financial Director of Harbin Pharmaceutical Group Co., Ltd. currently on record is Xiaodong Meng; five officers are currently on record for Harbin Pharmaceutical Group Co., Ltd., filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Harbin Pharmaceutical Group Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for SAMR — public search via GSXT (National Enterprise Credit Information Publicity System), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Harbin Pharmaceutical Group Co., Ltd.?
Two shareholders are currently on record for Harbin Pharmaceutical Group Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 81% — a majority holding — followed by DFA Emerging Markets Small Cap Series at 19%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Harbin Pharmaceutical Group Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Harbin Pharmaceutical Group Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Harbin Pharmaceutical Group Co., Ltd. have on record?
2 shareholders are shown on record for Harbin Pharmaceutical Group Co., Ltd..
Is Harbin Pharmaceutical Group Co., Ltd. still an active company?
Harbin Pharmaceutical Group Co., Ltd.'s status on SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is listed as active.
What is Harbin Pharmaceutical Group Co., Ltd.'s registered address?
The registered address on file for Harbin Pharmaceutical Group Co., Ltd. is Harbin, China.
Who are the officers/directors of Harbin Pharmaceutical Group Co., Ltd.?
The Vp, Secretary & Financial Director of Harbin Pharmaceutical Group Co., Ltd. currently on record is Xiaodong Meng; five officers are currently on record for Harbin Pharmaceutical Group Co., Ltd., filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Harbin Pharmaceutical Group Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Harbin Pharmaceutical Group Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Zavia's monitoring API can track changes to Harbin Pharmaceutical Group Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Harbin Pharmaceutical Group Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including China, so records like Harbin Pharmaceutical Group Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last synced on 29 September 2026.